Armistice Capital’s Clene CLNN Stock Holding History

Armistice Capital’s Portfolio CLNN Stock Details CLNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-682,374	Closed	-$3.13M	–	247
2024 Q3	$3.13M	Buy	+682,374	New	+$3.59M	0.05%	144

Other funds holding CLNN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Scoggin Management New York $935M AUM 301.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

LCM

Lunt Capital Management Holladay, Utah $273M AUM 15.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital's CLNN Position: Q4 2024 in Review

Armistice Capital sold out of Clene (CLNN) in Q4 2024, closing a stake of 682,374 shares — an estimated $3.13M sold.

Armistice Capital first reported a position in CLNN in Q3 2024 and held it in 1 quarter. The position peaked at $3.13M in Q3 2024. 27 funds tracked by Wall St. Rank hold CLNN as of Q4 2024.

Armistice Capital reported no remaining Clene position as of Q4 2024 after selling out during the quarter.
Armistice Capital sold 682,374 Clene shares in Q4 2024, an estimated $3.13M.
Armistice Capital first reported a position in Clene in Q3 2024 and held it in 1 quarter.
Armistice Capital's Clene position peaked at $3.13M in Q3 2024.
27 funds tracked by Wall St. Rank held Clene as of Q4 2024.

Based on Armistice Capital's 13F filing for Q4 2024, filed 14 Feb 2025.